Valuation: Enovis Corporation

Market Cap 1.07B 963M 899M 814M 1.53B 102B 1.54B 10.78B 4.21B 52.89B 4.02B 3.93B 170B P/E 2026 *
91.9x
P/E 2027 * 28.4x
Enterprise Value 2.38B 2.14B 1.99B 1.81B 3.39B 226B 3.42B 23.94B 9.35B 117B 8.92B 8.73B 378B EV / Sales 2026 *
1.02x
EV / Sales 2027 * 0.94x
Free-Float
98.36%
Yield 2026 *
-
Yield 2027 * -
1 day-2.21%
1 week+5.45%
Current month+1.64%
1 month+1.92%
3 months-24.67%
6 months-26.02%
Current year-30.29%
1 week 17.14
Extreme 17.145
19.12
1 month 16.7
Extreme 16.7
19.26
Current year 16.7
Extreme 16.7
31.66
1 year 16.7
Extreme 16.7
34.28
3 years 16.7
Extreme 16.7
65.03
5 years 16.7
Extreme 16.7
164.01
10 years 16.7
Extreme 16.7
164.01
Manager TitleAgeSince
Chief Executive Officer 61 12/05/2025
Director of Finance/CFO 47 01/01/2023
Chief Tech/Sci/R&D Officer - 01/01/2026
Director TitleAgeSince
Director/Board Member 59 04/04/2022
Director/Board Member 55 13/05/2008
Chairman 64 21/05/2025
Date Insider Type Main position Quantity % Market Cap. Importance
30/9/26 Free

Director

958 0.0017%
4/9/26 Buy

Chief Administrative Officer

2,660 0.0047%
4/9/26 Buy

Chief Executive Officer

13,035 0.0228%
Change 5-day change 1-year change 3-year change Capi.($)
-2.21%+5.45%-40.21%-61.14% 1.1B
+0.35%+4.29%-22.74%+13.32% 178B
+1.31%+10.20%-2.39%+30.95% 119B
-0.33%+2.26%-23.89%+9.21% 108B
+1.23%+0.99%-45.59%-9.75% 75.27B
+1.84%+5.96%+5.74%+77.89% 62.99B
-1.50%+0.04%+16.52%+64.60% 53.46B
+0.81%+4.85%+0.28%-26.98% 51.04B
+1.67%+4.41%-16.94%+24.13% 40.99B
-1.87%-0.98%+26.07%+9.56% 32.1B
Average +0.14%+3.59%-10.32%+13.18% 72.19B
Weighted average by Cap. +0.50%+4.12%-12.45%+20.12%

Financials

2026 *2027 *
Net sales 2.34B 2.1B 1.96B 1.78B 3.34B 223B 3.36B 23.55B 9.2B 116B 8.78B 8.59B 372B 2.45B 2.21B 2.06B 1.87B 3.5B 234B 3.52B 24.71B 9.65B 121B 9.21B 9.01B 390B
Net income 11.38M 10.23M 9.54M 8.65M 16.24M 1.08B 16.34M 115M 44.72M 562M 42.71M 41.78M 1.81B 29.72M 26.73M 24.94M 22.6M 42.44M 2.83B 42.7M 299M 117M 1.47B 112M 109M 4.72B
Net Debt 1.31B 1.17B 1.1B 993M 1.86B 124B 1.88B 13.15B 5.14B 64.52B 4.9B 4.8B 207B 1.25B 1.12B 1.04B 947M 1.78B 118B 1.79B 12.54B 4.9B 61.5B 4.67B 4.57B 198B
Projected Income Statement - Annual - Enovis Corporation
Logo Enovis Corporation
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
Employees
7,802
Date Price Change Volume
14/10/26 USD 18.57 -2.21% 1,142,268
13/10/26 USD 18.99 +4.05% 1,405,755
12/10/26 USD 18.25 +3.17% 910,923
09/10/26 USD 17.69 +1.49% 1,146,638
08/10/26 USD 17.43 -1.02% 2,305,143
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Enovis Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
18.57USD
Average target price
36.08USD
Spread / Average Target
+94.31%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Enovis Corporation
  1. Stock Market
  2. Stocks
  3. ENOV Stock